242 related articles for article (PubMed ID: 21816829)
1. Complex regulation of human NKG2D-DAP10 cell surface expression: opposing roles of the γc cytokines and TGF-β1.
Park YP; Choi SC; Kiesler P; Gil-Krzewska A; Borrego F; Weck J; Krzewski K; Coligan JE
Blood; 2011 Sep; 118(11):3019-27. PubMed ID: 21816829
[TBL] [Abstract][Full Text] [Related]
2. A possible mechanism of impaired NK cytotoxicity in cancer patients: down-regulation of DAP10 by TGF-beta1.
Lee JC; Lee KM; Ahn YO; Suh B; Heo DS
Tumori; 2011; 97(3):350-7. PubMed ID: 21789015
[TBL] [Abstract][Full Text] [Related]
3. TGF-β1 down-regulation of NKG2D/DAP10 and 2B4/SAP expression on human NK cells contributes to HBV persistence.
Sun C; Fu B; Gao Y; Liao X; Sun R; Tian Z; Wei H
PLoS Pathog; 2012; 8(3):e1002594. PubMed ID: 22438812
[TBL] [Abstract][Full Text] [Related]
4. The traffic of the NKG2D/Dap10 receptor complex during natural killer (NK) cell activation.
Roda-Navarro P; Reyburn HT
J Biol Chem; 2009 Jun; 284(24):16463-16472. PubMed ID: 19329438
[TBL] [Abstract][Full Text] [Related]
5. IL-21 down-regulates NKG2D/DAP10 expression on human NK and CD8+ T cells.
Burgess SJ; Marusina AI; Pathmanathan I; Borrego F; Coligan JE
J Immunol; 2006 Feb; 176(3):1490-7. PubMed ID: 16424177
[TBL] [Abstract][Full Text] [Related]
6. TGF-β1 improving abnormal pregnancy outcomes induced by Toxoplasma gondii infection: Regulating NKG2D/DAP10 and killer subset of decidual NK cells.
Xu X; Zhang J; Zhan S; Li Z; Liu X; Zhang H; Jiang Y; Hu X
Cell Immunol; 2017 Jul; 317():9-17. PubMed ID: 28438315
[TBL] [Abstract][Full Text] [Related]
7. Platelet-derived TGF-β1 mediates the down-modulation of NKG2D expression and may be responsible for impaired natural killer (NK) cytotoxicity in women with endometriosis.
Guo SW; Du Y; Liu X
Hum Reprod; 2016 Jul; 31(7):1462-74. PubMed ID: 27130956
[TBL] [Abstract][Full Text] [Related]
8. The killing effect of Tanshinol on breast cancer cells: insight into the reversion of TGF-β1-mediated suppression of NK cell functions.
Yang C; Qian C; Zhang T; Zheng W; Zhang S; Wang S; Wang A; Zhao Y; Lu Y
Front Biosci (Landmark Ed); 2021 Nov; 26(11):1106-1118. PubMed ID: 34856757
[No Abstract] [Full Text] [Related]
9. Inhibition of NK cell activity through TGF-beta 1 by down-regulation of NKG2D in a murine model of head and neck cancer.
Dasgupta S; Bhattacharya-Chatterjee M; O'Malley BW; Chatterjee SK
J Immunol; 2005 Oct; 175(8):5541-50. PubMed ID: 16210663
[TBL] [Abstract][Full Text] [Related]
10. Regulation of human DAP10 gene expression in NK and T cells by Ap-1 transcription factors.
Marusina AI; Burgess SJ; Pathmanathan I; Borrego F; Coligan JE
J Immunol; 2008 Jan; 180(1):409-17. PubMed ID: 18097042
[TBL] [Abstract][Full Text] [Related]
11. The activating NKG2D receptor assembles in the membrane with two signaling dimers into a hexameric structure.
Garrity D; Call ME; Feng J; Wucherpfennig KW
Proc Natl Acad Sci U S A; 2005 May; 102(21):7641-6. PubMed ID: 15894612
[TBL] [Abstract][Full Text] [Related]
12. Cloning, sequencing, and cell surface expression pattern of bovine immunoreceptor NKG2D and adaptor molecules DAP10 and DAP12.
Fikri Y; Nyabenda J; Content J; Huygen K
Immunogenetics; 2007 Aug; 59(8):653-9. PubMed ID: 17530242
[TBL] [Abstract][Full Text] [Related]
13. Ubiquitin-dependent endocytosis of NKG2D-DAP10 receptor complexes activates signaling and functions in human NK cells.
Quatrini L; Molfetta R; Zitti B; Peruzzi G; Fionda C; Capuano C; Galandrini R; Cippitelli M; Santoni A; Paolini R
Sci Signal; 2015 Oct; 8(400):ra108. PubMed ID: 26508790
[TBL] [Abstract][Full Text] [Related]
14. Elevated TGF-beta1 secretion and down-modulation of NKG2D underlies impaired NK cytotoxicity in cancer patients.
Lee JC; Lee KM; Kim DW; Heo DS
J Immunol; 2004 Jun; 172(12):7335-40. PubMed ID: 15187109
[TBL] [Abstract][Full Text] [Related]
15. NKG2D splice variants: a reexamination of adaptor molecule associations.
Rabinovich B; Li J; Wolfson M; Lawrence W; Beers C; Chalupny J; Hurren R; Greenfield B; Miller R; Cosman D
Immunogenetics; 2006 Apr; 58(2-3):81-8. PubMed ID: 16470377
[TBL] [Abstract][Full Text] [Related]
16. Human microRNA-1245 down-regulates the NKG2D receptor in natural killer cells and impairs NKG2D-mediated functions.
Espinoza JL; Takami A; Yoshioka K; Nakata K; Sato T; Kasahara Y; Nakao S
Haematologica; 2012 Sep; 97(9):1295-303. PubMed ID: 22491735
[TBL] [Abstract][Full Text] [Related]
17. Human tumor-derived exosomes down-modulate NKG2D expression.
Clayton A; Mitchell JP; Court J; Linnane S; Mason MD; Tabi Z
J Immunol; 2008 Jun; 180(11):7249-58. PubMed ID: 18490724
[TBL] [Abstract][Full Text] [Related]
18. An activating immunoreceptor complex formed by NKG2D and DAP10.
Wu J; Song Y; Bakker AB; Bauer S; Spies T; Lanier LL; Phillips JH
Science; 1999 Jul; 285(5428):730-2. PubMed ID: 10426994
[TBL] [Abstract][Full Text] [Related]
19. Silencing human NKG2D, DAP10, and DAP12 reduces cytotoxicity of activated CD8+ T cells and NK cells.
Karimi M; Cao TM; Baker JA; Verneris MR; Soares L; Negrin RS
J Immunol; 2005 Dec; 175(12):7819-28. PubMed ID: 16339517
[TBL] [Abstract][Full Text] [Related]
20. Soluble HLA-I-mediated secretion of TGF-beta1 by human NK cells and consequent down-regulation of anti-tumor cytolytic activity.
Ghio M; Contini P; Negrini S; Boero S; Musso A; Poggi A
Eur J Immunol; 2009 Dec; 39(12):3459-68. PubMed ID: 19830740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
